Virkon

Virkon is a multi-purpose disinfectant. It contains potassium peroxymonosulfate[1] (an oxidizing agent), sodium dodecylbenzenesulfonate (a detergent), sulfamic acid (a cleaning agent), and inorganic buffers. It is typically used for cleaning up hazardous spills, disinfecting surfaces and soaking equipment. The solution is used in many areas, including hospitals, laboratories, nursing homes, funeral homes, dental and veterinary facilities, and anywhere else where control of pathogens is required.[2]

1% Virkon has a wide spectrum of activity against viruses, some fungi, and bacteria.[3] This includes at least 300 strains/clinical isolates from 76 bacteria, 47 strains/clinical isolates from 35 viruses, and 45 strains/clinical isolates from 17 fungi.[4]

It has been proven effective against SARS-COV-2,[5] the virus that causes coronavirus disease 2019 (2019-nCoV).[6] However, it is less effective against spores and fungi than some alternative disinfectants.[7]

References

  1. ↑ "Lanxess plans to expand capacity for Oxone monopersulfate". cleanroomtechnology.com. Retrieved 2020-10-12.
  2. ↑ Antec International (2003). Virkon Broad Spectrum Disinfectant (EPA Label). "Archived copy" (PDF). Archived from the original on September 28, 2007. Retrieved November 22, 2006.{{cite web}}: CS1 maint: archived copy as title (link) CS1 maint: bot: original URL status unknown (link)
  3. ↑ Gasparini, R.; T. Pozzi; R. Magnelli; D. Fatighenti; E. Giotti; G. Poliseno; M. Pratelli; R. Severini; P. Bonanni; L. De Feo (1995-04-01). "Evaluation of in vitro efficacy of the disinfectant Virkon". European Journal of Epidemiology. 11 (2): 193–197. doi:10.1007/BF01719487. PMID 7672075. S2CID 19759687.
  4. ↑ "Virkon Disinfectant Powder". RMSupply. Retrieved 30 March 2020.
  5. ↑ "Virkon-S Disinfectant and Virucide for Agricultural Biosecurity". Syndel. Retrieved 2020-06-17.
  6. ↑ "LANXESS Coronavirus Solutions". Lanxess. Retrieved 30 March 2020.
  7. ↑ Herńndez, A.; E. Martró; L. Matas; M. Martín; V. Ausina (November 2000). "Assessment of in vitro efficacy of 1% Virkon against bacteria, fungi, viruses and spores by means of AFNOR guidelines". Journal of Hospital Infection. 46 (3): 203–209. doi:10.1053/jhin.2000.0818. ISSN 0195-6701. PMID 11073729.


This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.